← Back to VVOS

Vivos Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 14/08/2026Mar 2026Filed 20/05/2026Sep 2025Filed 19/11/2025Jun 2025Filed 14/08/2026Mar 2025Filed 20/05/2026Sep 2024Filed 19/11/2025Jun 2024Filed 19/11/2025Mar 2024Filed 19/11/2025
$5.2$5.1$6.8$3.8$3$3.9$4.1$3.4
−$5.5−$7.7−$5.4−$5−$3.9−$2.6−$1.9−$3.8
−$0.31−$0.52−$0.49−$0.55−$0.45−$0.40−$0.60−$1.63
1815119.18.66.63.22.3

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.